Treatment Area
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.

Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.

A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Start with a consultation and discuss which treatment category may be relevant to your concern.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.
Juvelook is an injectable collagen biostimulator formulated with poly-D,L-lactic acid (PDLLA) and non-crosslinked hyaluronic acid (HA). Designed to improve skin quality and support natural collagen production, it helps address fine lines, enlarged pores, uneven skin texture and early signs of skin ageing.
By combining PDLLA with HA, Juvelook supports gradual skin rejuvenation while improving hydration, firmness and overall skin appearance.
Juvelook helps address skin concerns associated with collagen loss, uneven texture and early signs of ageing.
Juvelook combines PDLLA and non-crosslinked hyaluronic acid to support skin rejuvenation through two complementary mechanisms. PDLLA stimulates fibroblast activity and encourages the body's natural collagen production over time. Meanwhile, hyaluronic acid helps attract and retain moisture, supporting skin hydration and improving its overall appearance. As collagen gradually develops, the skin may become smoother, firmer and more refined.
Face, Including the Cheeks, Under-Eye Area (When Clinically Suitable), Forehead and Other Selected Areas Requiring Skin Rejuvenation.
Approximately 30–60 minutes, depending on the treatment area and injection technique.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging, tenderness or temporary discomfort may occur during injection.
Temporary redness, swelling, bruising, tenderness or small injection bumps may occur following treatment. These effects generally improve over several days, although recovery varies between individuals.
A course of approximately 2–3 sessions, spaced around 4 weeks apart, may be recommended. The treatment plan is personalised according to individual skin condition and response.
Initial improvements in hydration and skin appearance may be noticed after treatment. Collagen-related improvements develop gradually over the following weeks to months, with results varying according to individual skin condition and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous treatments and any relevant health conditions.